An integrated molecular risk score early in life for subsequent childhood asthma risk.
Andreas BöckKathrin UrnerJana Kristin EckertMichael SalvermoserKristina LaubhahnSonja KunzeJörg KumbrinkMarc P HoeppnerKathrin KalkbrennerSimone KreimeierKirsten BeyerHamelmann EckardMichael KabeschMartin DepnerGesine HansenJosef RiedlerMarjut RoponenElisabeth Schmausser-HechfellnerCindy BarnigAmandine Divaret-ChauveauAnne M KarvonenJuha PekkanenRemo FreiCaroline RoduitRoger LauenerBianca Schaubnull nullPublished in: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (2024)
Applying epidemiological predictors alone showed moderate predictive abilities. Molecular markers from birth modestly improved prediction. Allergic symptoms/diagnoses enhanced the power of prediction, which is important for clinical practice and for the design of future studies with molecular markers.